Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Synucleinopathies Linked with Increased Mortality

JAMA Neurol; ePub 2017 May 15; Savica, et al

Individuals with multiple system atrophy with parkinsonism, dementia with Lewy bodies, and Parkinson disease dementia have increased mortality compared with the general population, according to a recent study. This population-based study used the Rochester Epidemiology Project medical records–linkage system to identify all residents in Olmsted County, MN, who received a diagnosis of parkinsonism from 1991 through 2010. Researchers found:

  • Of the 461 patients with synucleinopathies, 279 (60.5%) were men, and of the 452 referent participants, 272 (60.2%) were men.
  • From 1991 through 2010, the total number of individuals received a diagnosis of a synucleinopathy (309 [67%] of Parkinson disease, 81 [17.6%] of dementia with Lewy bodies, 55 [11.9%] of Parkinson disease dementia, and 16 [3.5%] of multiple system atrophy with parkinsonism).
  • Patients with multiple system atrophy with parkinsonism had the highest risk of death compared with referent participants.
  • Neurodegenerative disease was the most frequent cause of death listed on the death certificate for patients, and cardiovascular disease was the most frequent cause of death among referent participants.

Citation:

Savica R, Grossardt BR, Bower JH, et al. Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism. A population-based study. [Published online ahead of print May 15, 2017]. JAMA Neurol. doi:10.1001/jamaneurol.2017.0603.